Turning uncertainty into good decisions for chemicals, materials, and formulation R&D

Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.

Due to global warming endangering our planet and growing cost of energy, the thermal insulation materials are gaining more and more importance.

Many leading oil & gas and utilities companies are pursuing digital transformation to drive operational excellence. Across exploration, refining, power generation and distribution, petrochemical and other energy sectors, leaders are focused on reducing costs, mitigating risks, maximizing return on assets and streamlining project management.

Achieving successful sustainable development under REACH can help organizations overcome many existing product development issues. For example, collecting the data relevant for REACH compliance can foster improved materials inventory management or guide predictive toxicity studies for new products.priorities and approaches to digitalizing the lab. How intelligently planned formulations can ensure sustainable products.How toxicity databases can support toxicity prediction for new regulated substances.